National Eye Institute; Notice of Meeting, 18300-18301 [2014-07159]
Download as PDF
<![CDATA[
18300
Federal Register / Vol. 79, No. 62 / Tuesday, April 1, 2014 / Notices
relationships with federal and private
sector partners; (7) provides a national
platform for the coordination and
development of leading practices for
pharmacy services; (8) promotes
comprehensive and efficient pharmacy
management application and systems
use to ensure safe and effective
medication use; (9) manages quality
improvement activities; and (10)
promotes program integrity compliance
and improvement activities.
Section RR–30, Delegations of
Authority
All delegations of authority and redelegations of authority made to HRSA
officials that were in effect immediately
prior to this reorganization, and that are
consistent with this reorganization,
shall continue in effect pending further
re-delegation.
This reorganization is effective upon
date of signature.
Dated: March 20, 2014.
Mary K. Wakefield,
Administrator.
[FR Doc. 2014–07177 Filed 3–31–14; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Proposed Collection; 60-Day Comment
Request; Special Volunteer and Guest
Researcher Assignment, Office of the
Director (OD)
In compliance with the
requirement of Section 3506(c) (2) (A) of
SUMMARY:
the Paperwork Reduction Act of 1995,
for opportunity for public comment on
proposed data collection projects, the
Office of Intramural Research (OIR),
National Institutes of Health (NIH), will
publish periodic summaries of proposed
projects to be submitted to the Office of
Management and Budget (OMB) for
review and approval.
Written comments and/or suggestions
from the public and affected agencies
are invited on one or more of the
following points: (1) Whether the
proposed collection of information is
necessary for the proper performance of
the function of the agency, including
whether the information will have
practical utility; (2) The accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used; (3)
Ways to enhance the quality, utility, and
clarity of the information to be
collected; and (4) Ways to minimize the
burden of the collection of information
on those who are to respond, including
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology.
To Submit Comments and for Further
Information: To obtain a copy of the
data collection plans and instruments,
submit comments in writing, or request
more information on the proposed
project, contact: Mr. Larry Chloupek,
Management Liaison Director, OIR,
Office of the Director, NIH, 2 Center
Drive MSC 0235, Bethesda, MD 20892–
0235; or call non-toll-free number 301–
594–3992; or email your request,
including your address, to
larry.chloupek@nih.gov. Formal
requests for additional plans and
instruments must be requested in
writing.
Comment Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 60 days of the date of
this publication.
Proposed Collection: Special
Volunteer and Guest Researcher
Assignment, 0925–0177—
EXTENSION—Office of Intramural
Research (OIR), National Institutes of
Health (NIH).
Need and Use of Information
Collection: Form Number NIH–590 is a
single form completed by an NIH
official for each Guest Researcher or
Special Volunteer prior to his/her
arrival at the NIH. The information on
the form is necessary for the approving
official to reach a decision on whether
to allow a Guest Researcher to use NIH
facilities or whether to accept volunteer
services offered by a Special Volunteer.
If the original assignment is extended,
another form notating the extension is
completed to update the file.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours is
166.
DATES:
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondents
Special Volunteers ...........................................................................................
Guest Researchers ..........................................................................................
Dated: March 25, 2014.
Lawrence A. Tabak,
Deputy Director, NIH, Office of the Director.
[FR Doc. 2014–07263 Filed 3–31–14; 8:45 am]
National Institutes of Health
National Eye Institute; Notice of
Meeting
BILLING CODE 4140–01–P
mstockstill on DSK4VPTVN1PROD with NOTICES
1,250
410
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Advisory Eye Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
VerDate Mar<15>2010
16:02 Mar 31, 2014
Jkt 232001
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
Average
time per
response
Frequency
of response
1
1
6/60
6/60
Annual hour
burden
125
41
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
E:\FR\FM\01APN1.SGM
01APN1
Federal Register / Vol. 79, No. 62 / Tuesday, April 1, 2014 / Notices
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Eye Council.
Date: June 12, 2014.
Open: 8:30 a.m. to 2:00 p.m.
Agenda: Following opening remarks by the
Director, NEI, there will be presentations by
the staff of the Institute and discussions
concerning Institute Programs.
Place: National Institutes of Health,
Terrace Level Conference Room, 5635 Fishers
Lane, Bethesda, MD 20892.
Closed: 2:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications and/or proposals.
Place: National Institutes of Health,
Terrace Level Conference Room, 5635 Fishers
Lane, Bethesda, MD 20892.
Contact Person: Lore Anne Mc Nicol,
Ph.D., Director, Division Of Extramural
Research National Eye Institute, National
Institutes Of Health Bethesda, MD 20892,
(301) 451–2020.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page:
www.nei.nih.gov, where an agenda and any
additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.867, Vision Research,
National Institutes of Health, HHS)
Dated: March 26, 2014.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIH Support for
Conferences and Scientific Meetings (Parent
R13/U13).
Date: April 23–25, 2014.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health Room
3128, 6700B Rockledge Drive, Bethesda, MD
20817, (Virtual Meeting).
Contact Person: Jane K. Battles, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institutes of Health/NIAID, 6700B
Rockledge Drive, Room 3128 Bethesda, MD
20892–7616, 301–451–2744, battlesja@
mail.nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; ‘‘NIAID Clinical Trial
Planning Grants (R34) and Implementation
Grants and Cooperative Agreements (R01,
U01)’’.
Date: April 23, 2014.
Time: 1:30 p.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health Room
3122, 6700B Rockledge Drive, Bethesda, MD
20817.
Contact Person: Brenda Lange-Gustafson,
Ph.D., Scientific Review Officer, NIAID/NIH/
DHHS, Scientific Review Program, Room
3122, 6700–B Rockledge Drive, MSC–7616,
Bethesda, MD 20892–7616, 301–451–3684,
bgustafson@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
BILLING CODE 4140–01–P
Dated: March 26, 2014.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2014–07157 Filed 3–31–14; 8:45 am]
[FR Doc. 2014–07159 Filed 3–31–14; 8:45 am]
BILLING CODE 4140–01–P
National Institutes of Health
mstockstill on DSK4VPTVN1PROD with NOTICES
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
VerDate Mar<15>2010
16:02 Mar 31, 2014
Jkt 232001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2); notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The purpose of this
PO 00000
Frm 00045
Fmt 4703
Sfmt 9990
18301
meeting is to evaluate requests for
preclinical development resources for
potential new therapeutics for the
treatment of cancer. The outcome of the
evaluation will provide information to
internal NCI committees that will
decide whether NCI should support
requests and make available contract
resources for development of the
potential therapeutic to improve the
treatment of various forms of cancer.
The research proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the
proposed research projects, the
disclosure of which would constitute a
clearly unwarranted invasion of
personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel NCI
Experimental Therapeutics Program (Cycle
16 NExT).
Date: April 24, 2014.
Time: 8:30 a.m. to 4:30 p.m.
Agenda: To evaluate the NCI Experimental
Therapeutics Program Portfolio.
Place: National Institutes of Health, 9000
Rockville Pike, Building 31 Conference Room
6C06, Bethesda, MD 20892.
Contact Person:
Barbara Mroczkowski, Ph.D., Executive
Secretary, Discovery Experimental
Therapeutics Program, National Cancer
Institute, NIH, 31 Center Drive, Room
3A44, Bethesda, MD 20892, (301) 496–
4291, mroczkoskib@mail.nih.gov.
Joseph Tomaszewski, Ph.D., Executive
Secretary, Development Experimental
Therapeutics Program, National Cancer
Institute, NIH, 31 Center Drive, Room
3A44, Bethesda, MD 20892, (301) 496–
6711, tomaszej@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: March 26, 2014.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–07158 Filed 3–31–14; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\01APN1.SGM
01APN1
]]>Agencies
[Federal Register Volume 79, Number 62 (Tuesday, April 1, 2014)]
[Notices]
[Pages 18300-18301]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-07159]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Eye Institute; Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
National Advisory Eye Council.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and/or contract proposals
and the discussions could disclose confidential trade secrets or
commercial property such as patentable material, and personal
information concerning
[[Page 18301]]
individuals associated with the grant applications and/or contract
proposals, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: National Advisory Eye Council.
Date: June 12, 2014.
Open: 8:30 a.m. to 2:00 p.m.
Agenda: Following opening remarks by the Director, NEI, there
will be presentations by the staff of the Institute and discussions
concerning Institute Programs.
Place: National Institutes of Health, Terrace Level Conference
Room, 5635 Fishers Lane, Bethesda, MD 20892.
Closed: 2:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications and/or
proposals.
Place: National Institutes of Health, Terrace Level Conference
Room, 5635 Fishers Lane, Bethesda, MD 20892.
Contact Person: Lore Anne Mc Nicol, Ph.D., Director, Division Of
Extramural Research National Eye Institute, National Institutes Of
Health Bethesda, MD 20892, (301) 451-2020.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
Information is also available on the Institute's/Center's home
page: www.nei.nih.gov, where an agenda and any additional
information for the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.867,
Vision Research, National Institutes of Health, HHS)
Dated: March 26, 2014.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-07159 Filed 3-31-14; 8:45 am]
BILLING CODE 4140-01-P
